MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$13,056K
Tax credit
receivable
$3,351K
Prepaid expenses and
other current assets
$1,060K
In-process research and
development
$19,619K
Total current assets
$17,467K
Right of use asset
$803K
Property and equipment,
net
$222K
Deposits and other assets
$82K
Restricted cash
$46K
Total assets
$38,239K
Total liabilities and
stockholders' equity
$38,239K
Total liabilities
$22,856K
Total stockholders'
equity
$15,383K
Accumulated deficit
-$358,710K
Treasury stock at cost,
28,809 shares at...
$288K
Total current
liabilities
$10,014K
Non-current contingent
consideration
$10,004K
Loan payable -
non-current
$1,671K
Non-current deferred
research and development...
$815K
Non-current operating lease
liability
$352K
Additional paid-in capital
$373,592K
Accumulated other
comprehensive income (loss)
$755K
Common stock, 0.001 par
value 350,000,000...
$34K
Accrued expenses
$6,276K
Deferred research and
development tax...
$1,675K
Accounts payable
$1,014K
Operating lease
liability-current portion
$549K
Accrued employee
benefits
$443K
Loans
payable-current
$57K
Back
Back
Balance Sheet
source: myfinsight.com
Theriva Biologics, Inc. (TOVX)
Theriva Biologics, Inc. (TOVX)